SIRNAOMICS-B Initiates Legal Action Against Former Executives Over US$20.00 Million Investment

Bulletin Express21:27

Sirnaomics Ltd. (SIRNAOMICS-B) has filed a Writ of Summons with the High Court of Hong Kong on 14 August 2026 against three former members of its management—Dr. Lu Yang, Dr. Xiaochang Dai, and Mr. Yip Wing Kei—following an internal review of a prior investment totaling approximately US$20.00 million in a segregated portfolio of TradArt Flagship Investment SPC.

The company and its wholly owned subsidiary, Sirnaomics (Hong Kong) Limited, allege: 1. Breaches of fiduciary and other duties surrounding the decision-making, monitoring, and handling of the investment. 2. Unauthorized payments, subscriptions, or related arrangements undertaken without proper approval or due process. 3. Liability for damages, equitable compensation, interest, and associated legal costs.

Sirnaomics has engaged legal counsel and reserves the right to pursue further action against additional former management, officers, or third parties if warranted. The board will release updates in accordance with Hong Kong Listing Rules. Shareholders and potential investors are advised to exercise caution when trading the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103069318?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 21:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103069318","market":"hk","top_or_hot":-1,"title":"SIRNAOMICS-B Initiates Legal Action Against Former Executives Over US$20.00 Million Investment","media":"Bulletin Express","content":"<p>Sirnaomics Ltd. (SIRNAOMICS-B) has filed a Writ of Summons with the High Court of Hong Kong on 14 August 2026 against three former members of its management—Dr. Lu Yang, Dr. Xiaochang Dai, and Mr. Yip Wing Kei—following an internal review of a prior investment totaling approximately US$20.00 million in a segregated portfolio of TradArt Flagship Investment SPC.</p>\n<p>The company and its wholly owned subsidiary, Sirnaomics (Hong Kong) Limited, allege:\n1. Breaches of fiduciary and other duties surrounding the decision-making, monitoring, and handling of the investment.\n2. Unauthorized payments, subscriptions, or related arrangements undertaken without proper approval or due process.\n3. Liability for damages, equitable compensation, interest, and associated legal costs.</p>\n<p>Sirnaomics has engaged legal counsel and reserves the right to pursue further action against additional former management, officers, or third parties if warranted. The board will release updates in accordance with Hong Kong Listing Rules. Shareholders and potential investors are advised to exercise caution when trading the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIRNAOMICS-B Initiates Legal Action Against Former Executives Over US$20.00 Million Investment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIRNAOMICS-B Initiates Legal Action Against Former Executives Over US$20.00 Million Investment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 21:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sirnaomics Ltd. (SIRNAOMICS-B) has filed a Writ of Summons with the High Court of Hong Kong on 14 August 2026 against three former members of its management—Dr. Lu Yang, Dr. Xiaochang Dai, and Mr. Yip Wing Kei—following an internal review of a prior investment totaling approximately US$20.00 million in a segregated portfolio of TradArt Flagship Investment SPC.</p>\n<p>The company and its wholly owned subsidiary, Sirnaomics (Hong Kong) Limited, allege:\n1. Breaches of fiduciary and other duties surrounding the decision-making, monitoring, and handling of the investment.\n2. Unauthorized payments, subscriptions, or related arrangements undertaken without proper approval or due process.\n3. Liability for damages, equitable compensation, interest, and associated legal costs.</p>\n<p>Sirnaomics has engaged legal counsel and reserves the right to pursue further action against additional former management, officers, or third parties if warranted. The board will release updates in accordance with Hong Kong Listing Rules. Shareholders and potential investors are advised to exercise caution when trading the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02257","symbol_name":"圣诺医药-B","start_time":0,"source_url":"","article_id":"1103069318","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103069318","pubTimestamp":1786714073,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sirnaomics Ltd. (SIRNAOMICS-B) has filed a Writ of Summons with the High Court of Hong Kong on 14 August 2026 against three former members of its management—Dr. Lu Yang, Dr. Xiaochang Dai, and Mr....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02257":"圣诺医药-B"},"translate_title":"SIRNAOMICS-B 对投资 2000 万美元的前高管提起法律诉讼","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02257":1},"content_text":"Sirnaomics Ltd. (SIRNAOMICS-B) has filed a Writ of Summons with the High Court of Hong Kong on 14 August 2026 against three former members of its management—Dr. Lu Yang, Dr. Xiaochang Dai, and Mr. Yip Wing Kei—following an internal review of a prior investment totaling approximately US$20.00 million in a segregated portfolio of TradArt Flagship Investment SPC.\nThe company and its wholly owned subsidiary, Sirnaomics (Hong Kong) Limited, allege:\n1. Breaches of fiduciary and other duties surrounding the decision-making, monitoring, and handling of the investment.\n2. Unauthorized payments, subscriptions, or related arrangements undertaken without proper approval or due process.\n3. Liability for damages, equitable compensation, interest, and associated legal costs.\nSirnaomics has engaged legal counsel and reserves the right to pursue further action against additional former management, officers, or third parties if warranted. The board will release updates in accordance with Hong Kong Listing Rules. Shareholders and potential investors are advised to exercise caution when trading the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103069318","isCrawlerRequest":true}